Peer Reviewed Publication Library

Acellular human amniotic fluid-derived extracellular vesicles as a novel anti-inflammatory therapeutic against SARS-COV-2 Infection

Extracellular Vesicles: A promising therapy against SARS-CoV-2 infection

Human amniotic fluid derived extracellular vesicles attenuate T Cell immune response

Proof-of-concept trial of an amniotic fluid-derived extracellular vesicle biologic for treating high risk patients with mild-to-moderate acute COVID-19 infection, Biomaterials and Biosystems

Amniotic fluid-derived extracellular vesicles: characterization and therapeutic efficacy in an experimental model of bronchopulmonary dysplasia, Cytotherapy

Case Report: Administration of Amniotic Fluid-Derived Nanoparticles in Three Severely Ill COVID-19 Patients

Treatment of a COVID-19 long hauler with an amniotic fluid-derived extracellular vesicle biologics